A clinical pharmacologic study of chemotherapy and x-ray therapy in lung cancer
- 31 August 1967
- journal article
- clinical trial
- Published by Elsevier in American Journal Of Medicine
- Vol. 43 (2), 186-193
- https://doi.org/10.1016/0002-9343(67)90163-5
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Objective evaluation of change in tumor size in lung cancer patients with nonmeasurable diseaseCancer, 1966
- MODIFICATION OF RADIATION RESPONSE OF TUMORS BY ACTINOMYCIN DAmerican Journal of Roentgenology, 1966
- Controlled Studies of the Therapy of Nonresectable Cancer of the Lung: I. MethodologyThe Annals of Thoracic Surgery, 1965
- Combined use of AB-132 (Meturedepa, Turloc) and X irradiation in the management of advanced bronchogenic carcinomaCancer, 1964
- Further Observations on the Use of Combination 5-fluorouracil and Supervoltage Irradiation Therapy in the Treatment of Advanced Carcinoma of the BladderJournal of Urology, 1963
- Comparative trial of chemotherapy and radiotherapy in patients with non-resectable cancer of the lungAmerican Journal Of Medicine, 1963
- Clinical method of testing radiation-sensitizing agents in squamous cell carcinomaCancer, 1963
- Combined chemotherapy and irradiation in inoperable bronchogenic carcinomaCancer, 1962
- Massive Intra-aortic Injections of Nitrogen Mustard (Dichloren), 5-Fluorouracil, Nitromin, and Endoxan Prior to Roentgen Irradiation for Advanced Tumors of the UterusRadiology, 1962
- Potentiation of X-Ray Effects by Actinomycin DRadiology, 1959